Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 3 1Phase 1 1

Status

Completed 8Terminated 5Recruiting 1

Sponsor Class

NIH 2INDUSTRY 2OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 2Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Ovarian Neoplasms 2Carcinoma 2Rectal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Interventional × interferon gamma-1b × Clear all
NCT02948426 2026-01-08

Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
18 enrolled 19 charts
Gynecologic

Carcinoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03747484 2025-03-06

Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
7 enrolled 15 charts
Dermatologic

Neoplasm Metastasis, Carcinoma, Merkel Cell

NCT00002796 2013-02-01

Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer

National Cancer Institute (NCI)

Phase 1/2 Terminated
46 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00047632 2007-11-01

Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer

InterMune

Phase 3 Terminated
847 enrolled
Gynecologic

Carcinoma, Neoplasms, Ovarian Neoplasms

NCT00057447 2007-11-01

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

InterMune

Phase 1/2 Terminated
24 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡